Skip to content

Post-SOPHrology Cancer Patients' anxieTY Report

Post-SOPHrology Cancer Patients' anxieTY Report

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03707301
Acronym
SOPHTY
Enrollment
17
Registered
2018-10-16
Start date
2019-01-24
Completion date
2021-05-12
Last updated
2022-02-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Keywords

Cancer, Sophrology, Anxiety, Hospital Anxiety and Depression scale

Brief summary

Cancer is pathology with a high impact on patients and relatives quality of life. Most of the time, it is a stressful trial. Professionals have often resort to pharmaceutical solutions, but sometimes, it is not sufficient. So, patients resort to alternative and complementary medicines, as sophrology. In Lucien Neuwirth Cancer Institute, patients can benefit from sophrology. Anxiety levels have never been reported before and after sessions. Indeed, the present study wants to report anxiety levels before, after, and one and three weeks after session. Levels of satisfaction will also be reported.

Detailed description

Cancer is pathology with a high impact on patients and relatives quality of life. Most of the time, it is a stressful trial. Professionals have often resort to pharmaceutical solutions, but sometimes, it is not sufficient. So, patients resort to alternative and complementary medicines, as sophrology. In Lucien Neuwirth Cancer Institute, patients can benefit from sophrology. Anxiety levels have never been reported before and after sessions. Indeed, the present study wants to report anxiety levels before, after, and one and three weeks after session. Levels of satisfaction will also be reported.

Interventions

OTHERQuestionnaires

Questionnaires of satisfaction and the Hospital Anxiety and Depression scale.

Sponsors

Institut de Cancérologie de la Loire
CollaboratorOTHER
Centre Hospitalier Universitaire de Saint Etienne
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

\- Patient performing at least one session of sophrology in the Lucien Neuwirth Cancer Institute

Exclusion criteria

* Protected patient (according to the law), * Patient with incapacity to complete questionnaires, * Patient with incapacity to perform sophrologic movements.

Design outcomes

Primary

MeasureTime frameDescription
Level of anxiety difference1 hourLevel of anxiety after sophrology session will be compared to the level of anxiety before session, on a visual scale from 0 to 10. The scale is 10 centimeters long, printed on a paper.

Secondary

MeasureTime frameDescription
Level of anxiety difference1 monthLevel of anxiety after a second session of sophrology will be compared to the level of anxiety reported before the first sophrology session, according to the Hospital Anxiety and Depression scale, part A. The part A is composed of seven questions, with a score obtained between 0 and 28. A score between : * 7 or less : no symptomatology ; * 8 to 10 : doubtful symptomatology ; * 11 and more : certain symptomatology.
Level of depression difference1 monthLevel of depression after a second session of sophrology will be compared to the level of depression reported before the first sophrology session, according to the Hospital Anxiety and Depression scale, part B. The part B is composed of seven questions, with a score obtained between 0 and 28. A score between : * 7 or less : no symptomatology ; * 8 to 10 : doubtful symptomatology ; * 11 and more : certain symptomatology.
Sessions duration1 hourDuration of sessions will be reported, unit used: minutes.
Number of sessions1 monthNumber of sessions performed during one month will be reported.
Patients satisfaction1 monthPatients satisfaction will be reported during one month, as many times as they performed sophrology sessions, on a visual scale from 0 to 10. The scale is 10 centimeters long, printed on a paper.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026